Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A double-blind, randomized, placebo-controlled, multicenter 4-week study to assess the effect of alendronate 70 mg and vitamin D3 2800 IU once weekly on fractional calcium absorption in postmenopausal osteoporotic women

Trial Profile

A double-blind, randomized, placebo-controlled, multicenter 4-week study to assess the effect of alendronate 70 mg and vitamin D3 2800 IU once weekly on fractional calcium absorption in postmenopausal osteoporotic women

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jan 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Alendronic acid/colecalciferol (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Sponsors Merck & Co; Merck Sharp & Dohme
  • Most Recent Events

    • 01 Aug 2011 Results published in the Journal of Bone and Mineral Research.
    • 11 Apr 2008 New trial record.
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top